WG
ADPT icon

Winton Group’s Adaptive Biotechnologies ADPT Stock Holding History

Winton Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,700
Closed -$807K – 1087
2025
Q4 		$807K Buy
+49,700
New +$811K 0.03% 532
2023
Q2 		– Sell
-26,383
Closed -$233K – 757
2023
Q1 		$233K Buy
26,383
+2,843
+12% +$25.1K 0.01% 869
2022
Q4 		$180K Buy
23,540
+1,140
+5% +$8.87K 0.01% 874
2022
Q3 		$159K Sell
22,400
-2,076
-8% -$19.6K 0.01% 886
2022
Q2 		$198K Buy
24,476
+5,597
+30% +$49.2K 0.01% 905
2022
Q1 		$262K Buy
18,879
+3,579
+23% +$56.3K 0.01% 849
2021
Q4 		$429K Buy
15,300
+1,103
+8% +$33.8K 0.03% 719
2021
Q3 		$483K Sell
14,197
-3,441
-20% -$124K 0.03% 879
2021
Q2 		$721K Buy
17,638
+634
+4% +$24.6K 0.04% 707
2021
Q1 		$685K Sell
17,004
-1,524
-8% -$82.5K 0.04% 698
2020
Q4 		$1.1M Sell
18,528
-14,553
-44% -$750K 0.08% 355
2020
Q3 		$1.61M Buy
+33,081
New +$1.39M 0.05% 630

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Winton Group's ADPT Position: Q1 2026 in Review

Winton Group sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 49,700 shares — an estimated $807K sold.

Winton Group first reported a position in ADPT in Q3 2020 and held it in 12 quarters. The position peaked at $1.61M in Q3 2020. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Winton Group reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Winton Group sold 49,700 Adaptive Biotechnologies shares in Q1 2026, an estimated $807K.
  • Winton Group first reported a position in Adaptive Biotechnologies in Q3 2020 and held it in 12 quarters.
  • Winton Group's Adaptive Biotechnologies position peaked at $1.61M in Q3 2020.
  • 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.